3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Mouth Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Tongue Neoplasms
1
Solid Tumor
1
Skin Lesion
1
Renal Colic
1
Rectal Neoplasms
1
Pregnancy, Ectopic
1
Postoperative Complications
1
Pneumonia
1
Pleural Effusion
1
Phlebitis
1
Pancreatic Neoplasms
1
Lymphoma, Primary Effusion
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lymphedema
1
Liver Neoplasms
1
Kidney Neoplasms
1
Gastrointestinal Neoplasms
1
Cysts
1
Cholecystitis
1
Brain Neoplasms
1
Arachnodactyly
1
Abortion, Spontaneous
1
Interventions
Nivolumab
11
pembrolizumab
10
Ipilimumab
9
Cyclophosphamide
6
tebentafusp
5
Interleukin-2
4
Blood Specimen Collection
4
fludarabine phosphate
3
fludarabine
3
Specimen Handling
3
Radiosurgery
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
relatlimab
2
lenvatinib
2
cemiplimab
2
binimetinib
2
aflibercept
2
Surveys and Questionnaires
2
Dacarbazine
2
Crizotinib
2
Carmustine
2
Biopsy
2
ulixertinib
1
trametinib
1
sargramostim
1
ruxolitinib
1
omipalisib
1
olaparib
1
lifileucel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
Ultrasonography
×
1 year
×
Clear all
No trials found.